{"id":"https://openalex.org/W2586591937","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2019","title":"BTTC08-01: A phase II study of bevacizumab and erlotinib after radiation therapy and temozolomide in patients with newly diagnosed glioblastoma (GBM) without MGMT promoter methylation.","display_name":"BTTC08-01: A phase II study of bevacizumab and erlotinib after radiation therapy and temozolomide in patients with newly diagnosed glioblastoma (GBM) without MGMT promoter methylation.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2586591937","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2019","mag":"2586591937"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.2019","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2019","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2019","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029952866","display_name":"Jeffrey J. Raizer","orcid":"https://orcid.org/0009-0003-8469-2509","observed_orcids":["https://orcid.org/0009-0003-8469-2509"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey J. Raizer","raw_affiliation_strings":["Northwestern University, Feinberg School of Medicine, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Feinberg School of Medicine, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020238544","display_name":"Pierre Giglio","orcid":"https://orcid.org/0000-0001-5165-0984","observed_orcids":["https://orcid.org/0000-0001-5165-0984"]},"institutions":[{"id":"https://openalex.org/I4210095449","display_name":"MUSC Hollings Cancer Center","ror":"https://ror.org/00w52vt71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pierre Giglio","raw_affiliation_strings":["MUSC Hollings Cancer Center, Charleston, SC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MUSC Hollings Cancer Center, Charleston, SC","institution_ids":["https://openalex.org/I4210095449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010077225","display_name":"Jethro Lisien Hu","orcid":"https://orcid.org/0000-0002-5450-7988","observed_orcids":["https://orcid.org/0000-0002-5450-7988"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jethro Lisien Hu","raw_affiliation_strings":["Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110346854","display_name":"Morris D. Groves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Morris D. Groves","raw_affiliation_strings":["Texas Oncology, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology, Austin, TX","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087112179","display_name":"Ryan Thomas Merrell","orcid":"https://orcid.org/0000-0002-8076-0768","observed_orcids":["https://orcid.org/0000-0002-8076-0768"]},"institutions":[{"id":"https://openalex.org/I1339509835","display_name":"Endeavor Health","ror":"https://ror.org/04tpp9d61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1339509835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Merrell","raw_affiliation_strings":["Northshore University, Evanston, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northshore University, Evanston, IL","institution_ids":["https://openalex.org/I1339509835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106083527","display_name":"Charles A. Conrad","orcid":"https://orcid.org/0000-0001-5178-8465","observed_orcids":["https://orcid.org/0000-0001-5178-8465"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. Conrad","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068495908","display_name":"Surasak Phuphanich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surasak Phuphanich","raw_affiliation_strings":["Neuro-Oncology Program, Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuro-Oncology Program, Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037535298","display_name":"Vinay K. Puduvalli","orcid":"https://orcid.org/0000-0001-8396-9500","observed_orcids":["https://orcid.org/0000-0001-8396-9500"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vinay K. Puduvalli","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062153042","display_name":"Monica Elena Loghin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica Elena Loghin","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111765097","display_name":"Nina A. Paleologos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49886154","display_name":"Rush University","ror":"https://ror.org/01k9xac83","country_code":"US","type":"education","lineage":["https://openalex.org/I49886154"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nina Paleologos","raw_affiliation_strings":["Rush University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rush University, Chicago, IL","institution_ids":["https://openalex.org/I49886154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111550344","display_name":"W.K. Alfred Yung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. K. Alfred Yung","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083697768","display_name":"Brian D. Vaillant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian D. Vaillant","raw_affiliation_strings":["The Methodist Hospital, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Methodist Hospital, Houston, TX","institution_ids":["https://openalex.org/I1295876152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006853372","display_name":"Jeremy David Rudnick","orcid":"https://orcid.org/0000-0002-1442-4299","observed_orcids":["https://orcid.org/0000-0002-1442-4299"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy David Rudnick","raw_affiliation_strings":["Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028023803","display_name":"Marc Charles Chamberlain","orcid":"https://orcid.org/0009-0009-5285-2807","observed_orcids":["https://orcid.org/0009-0009-5285-2807","https://orcid.org/0000-0002-1613-1123"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc C. Chamberlain","raw_affiliation_strings":["University of Washington, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112081892","display_name":"Nicholas A. Vick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1339509835","display_name":"Endeavor Health","ror":"https://ror.org/04tpp9d61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1339509835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Vick","raw_affiliation_strings":["Northshore University, Evanston, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northshore University, Evanston, IL","institution_ids":["https://openalex.org/I1339509835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041824343","display_name":"Sean Aaron Grimm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean Aaron Grimm","raw_affiliation_strings":["University of Minnesota, Minneapolis, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota, Minneapolis, MN","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056029006","display_name":"Ivo W. Tremont\u2010Lukats","orcid":"https://orcid.org/0000-0001-8086-0200","observed_orcids":["https://orcid.org/0000-0001-8086-0200"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivo Tremont-Lukats","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104124631","display_name":"John Frederick De Groot","orcid":"https://orcid.org/0000-0003-1454-6461","observed_orcids":["https://orcid.org/0000-0003-1454-6461"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Frederick De Groot","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063290790","display_name":"Kenneth Aldape","orcid":"https://orcid.org/0000-0001-5119-7550","observed_orcids":["https://orcid.org/0000-0001-5119-7550"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth D. Aldape","raw_affiliation_strings":["The University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064627876","display_name":"Mark R. Gilbert","orcid":"https://orcid.org/0000-0003-2556-9722","observed_orcids":["https://orcid.org/0000-0003-2556-9722"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R. Gilbert","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"2019","last_page":"2019"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9179999828338623},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.859000027179718},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8759999871253967},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9110000133514404},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.6880000233650208},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.8040000200271606},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.9449999928474426},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8740000128746033},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8029999732971191},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6650000214576721},{"id":"https://openalex.org/keywords/newly-diagnosed-glioblastoma","display_name":"newly diagnosed glioblastoma","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.945318341255188},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8933457136154175},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8443371057510376},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.6626587510108948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6615447998046875},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5284538269042969},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4796193540096283},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45317891240119934},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4187565743923187},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36978816986083984},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3489952087402344},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3359854221343994},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31775572896003723},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2603435516357422},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.0813448429107666}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.2019","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2019","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2019","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2110966639","https://openalex.org/W2723616706","https://openalex.org/W2830189318","https://openalex.org/W2196951954","https://openalex.org/W4251989766","https://openalex.org/W2962975363","https://openalex.org/W2167923186","https://openalex.org/W4249740696","https://openalex.org/W2270769175","https://openalex.org/W2527516493"],"abstract_inverted_index":{"2019^":[0],"Background:":[1],"Patients":[2],"(pts)":[3],"with":[4,6,15,48,78,98,175,199,255,266],"GBM":[5,166,254],"unmethylated":[7,50,100,256,270],"MGMT":[8,49,91,101,257,271],"have":[9],"a":[10,34],"worse":[11],"prognosis":[12],"than":[13,67],"those":[14],"methylated":[16],"MGMT.":[17],"Novel":[18],"approaches":[19],"for":[20,90,163],"this":[21,61],"poor":[22],"risk":[23],"group":[24],"are":[25,55],"warranted.":[26],"The":[27,191],"Brain":[28],"Tumor":[29],"Trials":[30],"Collaborative":[31],"(BTTC)":[32],"performed":[33],"phase":[35],"II":[36],"trial":[37,204,287],"evaluating":[38],"standard":[39],"chemoradiation":[40],"followed":[41],"by":[42,137],"bevacizumab":[43,120,250],"and":[44,53,84,111,126,167,216,228,251,277],"erlotinib":[45,127,252],"in":[46,253,268],"patients":[47,77,106,154,201],"GBM.":[51],"EGFR":[52],"VEGFR":[54],"upregulated":[56],"during":[57],"radiation":[58],"suggesting":[59],"that":[60],"combination":[62],"could":[63],"be":[64],"more":[65],"effective":[66],"post-radiation":[68],"adjuvant":[69],"temozolomide":[70],"(TMZ).":[71],"Methods:":[72],"After":[73],"informed":[74],"consent,":[75],"adult":[76],"supratentorial":[79],"GBM,":[80],"KPS":[81,187],"\u2265":[82],"70":[83],">":[85],"1":[86,162,168],"cm2":[87],"tumor":[88],"block":[89],"promoter":[92,102],"analysis":[93],"were":[94,103,155,158,239],"screened.":[95],"Only":[96],"tumors":[97],"confirmed":[99],"enrolled.":[104],"All":[105],"received":[107,119],"RT":[108,117],"+":[109],"TMZ":[110],"then":[112],"approximately":[113],"4":[114,134,200,212],"weeks":[115,125],"after":[116,170],"they":[118],"10":[121],"mg/kg":[122],"every":[123,140],"2":[124,141],"150":[128],"mg/day,":[129],"continuously.":[130],"One":[131],"cycle":[132],"was":[133,139,182,188,196],"weeks;":[135],"evaluation":[136],"MRI":[138],"cycles.":[142],"Treatment":[143],"continued":[144],"until":[145],"disease":[146],"progression":[147],"or":[148],"intolerable":[149],"adverse":[150],"events.":[151],"Results:":[152],"115":[153],"screened;":[156],"48":[157],"enrolled":[159],"(2":[160],"unevaluable:":[161],"an":[164],"infratentoral":[165],"withdrew":[169],"7":[171],"days":[172],"of":[173,194,208],"treatment)":[174],"29":[176],"men,":[177],"17":[178],"women.":[179],"Median":[180,219],"age":[181],"56":[183],"yrs":[184],"(29-75);":[185],"median":[186,192,229],"90":[189],"(70-90).":[190],"number":[193],"cycles":[195],"8":[197],"(2-38)":[198],"remaining":[202],"on":[203],"at":[205],"the":[206,275],"time":[207],"analysis.":[209],"Objective":[210],"responses:":[211],"CR,":[213],"12":[214],"PR":[215],"30":[217],"SD.":[218],"PFS":[220],"is":[221,258,264,283],"7.3":[222],"months":[223,232],"(95%":[224,233],"CI":[225,234],"(6.4,":[226],"11))":[227],"OS":[230],"14.2":[231],"(10.7,":[235],"not":[236],"reached)).":[237],"There":[238],"no":[240],"unexpected":[241],"toxicities;":[242],"grade":[243],"3/4":[244],"rate":[245],"<":[246],"5%.":[247],"Conclusions:":[248],"Adjuvant":[249],"well":[259],"tolerated.":[260],"Preliminary":[261],"efficacy":[262],"data":[263],"comparable":[265],"outcomes":[267],"similar":[269],"patient":[272],"populations":[273],"from":[274],"EORTC/NCIC":[276],"RTOG":[278],"0525":[279],"studies.":[280],"Tissue":[281],"correlation":[282],"being":[284],"performed.":[285],"Clinical":[286],"information:":[288],"NCT00720356.":[289]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-17T00:00:00"}